Agenus Inc (AGEN)
16.72
+2.60
(+18.41%)
USD |
NASDAQ |
Jun 28, 16:00
16.98
+0.26
(+1.56%)
After-Hours: 20:00
Agenus Research and Development Expense (TTM)
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2010 | 13.30M |
| June 30, 2010 | 14.23M |
| March 31, 2010 | 16.63M |
| December 31, 2009 | 16.90M |
| September 30, 2009 | 17.38M |
| June 30, 2009 | 19.03M |
| March 31, 2009 | 19.84M |
| December 31, 2008 | 20.66M |
| September 30, 2008 | 20.61M |
| June 30, 2008 | 21.35M |
| March 31, 2008 | 21.56M |
| December 31, 2007 | 21.79M |
| September 30, 2007 | 24.16M |
| June 30, 2007 | 24.28M |
| March 31, 2007 | 26.10M |
| December 31, 2006 | 28.97M |
| September 30, 2006 | 33.19M |
| June 30, 2006 | 38.94M |
| March 31, 2006 | 44.16M |
| December 31, 2005 | 46.63M |
| Date | Value |
|---|---|
| September 30, 2005 | 46.47M |
| June 30, 2005 | 44.29M |
| March 31, 2005 | 42.08M |
| December 31, 2004 | 41.72M |
| September 30, 2004 | 42.21M |
| June 30, 2004 | 45.80M |
| March 31, 2004 | 46.67M |
| December 31, 2003 | 46.04M |
| September 30, 2003 | 46.98M |
| June 30, 2003 | 43.93M |
| March 31, 2003 | 42.13M |
| December 31, 2002 | 39.98M |
| September 30, 2002 | 5.801M |
| June 30, 2002 | 36.86M |
| March 31, 2002 | 33.36M |
| December 31, 2001 | 31.36M |
| September 30, 2001 | 59.93M |
| June 30, 2001 | 23.01M |
| March 31, 2001 | 20.38M |
| December 31, 2000 | 17.58M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ligand Pharmaceuticals Inc | 23.84M |
| Artivion Inc | 28.43M |
| Bioventus Inc | 12.27M |
| AIM ImmunoTech Inc | 10.84M |
| Protalix BioTherapeutics Inc | 14.13M |